Before the pandemic, many laboratories were already facing financial challenges due to severe downward pricing pressure caused by multi-year price cuts to the Medicare Part B clinical laboratory fee schedule. Entering the COVID-19 era, many labs saw daily volumes dry up and turned to COVID testing to remain in business.
Revenue-enhancing Best Practices Accelerate Claim Reimbursement and Ensure HRSA Compliance
